Philip J. Young

2013 - AmpliPhi Biosciences

In 2013, Philip J. Young earned a total compensation of $2.4M as President and CEO and Director at AmpliPhi Biosciences, a 18% increase compared to previous year.

Compensation breakdown

Option Awards$1,856,000
Salary$400,000
Other$105,396
Total$2,361,396

Young received $1.9M in option awards, accounting for 79% of the total pay in 2013.

Young also received $400K in salary and $105.4K in other compensation.

Rankings

In 2013, Philip J. Young's compensation ranked 3,315th out of 12,286 executives tracked by ExecPay. In other words, Young earned more than 73.0% of executives.

ClassificationRankingPercentile
All
3,315
out of 12,286
73rd
Division
Manufacturing
1,126
out of 4,612
76th
Major group
Chemicals And Allied Products
298
out of 1,466
80th
Industry group
Drugs
204
out of 1,160
82nd
Industry
Biological Products, Except Diagnostic Substances
28
out of 200
86th
Source: SEC filing on April 30, 2014.

Young's colleagues

We found two more compensation records of executives who worked with Philip J. Young at AmpliPhi Biosciences in 2013.

2013

David Harper

AmpliPhi Biosciences

Chief Scientific Officer

2013

Kelley Wendt

AmpliPhi Biosciences

Chief Financial Officer

In-depth

You may also like